Last reviewed · How we verify

NCT04222049

Application of Vibration Wave Therapy to the Children Suffering From Cerebral Palsy and Tongue Spastic Dysarthria

Completed NA Last updated 16 June 2020
What this trial tests

NA trial testing Vibro Tactile Gadget in Cerebral Palsy in 12 participants. Completed in 14 June 2020.

Timeline
15 July 2019
Primary endpoint
12 May 2020
14 June 2020

Quick facts

Lead sponsorNational University of Science and Technology, Pakistan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date15 July 2019
Primary completion12 May 2020
Estimated completion14 June 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

National University of Science and Technology, Pakistan

Who can join

Adults 4 to 8, any sex, with Cerebral Palsy or Spastic Dysarthria. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vibration therapy is the widely used in many neurological disorders for different type of problems. Recently, it is being used by researchers for the betterment of motor disorders and muscle movements of the cerebral palsy patients and significant results are obtained. Investigators are conducting this research to explore that whether this therapy can have some effect on the Spastic Tongue Dysarthria of the Cerebral Palsy patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other National University of Science and Technology, Pakistan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04222049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing